On Monday, iRhythm Technologies Inc. (NASDAQ:IRTC) reported preliminary fourth quarter operational highlights.
The digital health company anticipates full-year 2025 revenue to exceed the high end of the previously stated guidance range of $740 million provided in October 2025, driven by record revenue unit volume during the fourth quarter of 2025.
The analysts estimated a consensus of $737.95 million.
For fiscal year 2026, iRhythm expects revenue of approximately $870 million to $880 million, up approximately 17% to 18% year-over-year growth versus the consensus of $862.68 million.
For 2026, the company expects an adjusted EBITDA margin of approximately 11.5% to 12.5%.
“As we enter 2026, we’re well-positioned to accelerate our leadership with multiple growth catalysts ahead, including deepening penetration in primary care and population health through AI-powered risk stratification partnerships, momentum within mobile cardiac telemetry, expansion into adjacent …